Svensson Miriam, Dihge Looket
Department of Surgery, Kristianstad Central Hospital, SE-291 33 Kristianstad, Sweden.
Department of Clinical Sciences, Division of Surgery, Lund University, SE-221 85 Lund, Sweden.
J Pers Med. 2022 Aug 4;12(8):1283. doi: 10.3390/jpm12081283.
Postmastectomy radiotherapy (PMRT) following immediate breast reconstruction (IBR) is associated with postoperative complications. Although the incidence of node-positive breast cancer is declining, a separate sentinel lymph node biopsy (SLNB) is still performed before mastectomy when IBR is planned, in order to evaluate nodal status and the need for PMRT. This study assessed the impact of staged SLNB on the breast reconstructive planning, and presents common clinicopathological characteristics of breast cancer with macrometastatic nodal spread where staged SLNB would be beneficial to indicate PMRT. Medical records of breast cancer patients scheduled for mastectomy and IBR at Skåne University Hospital, Sweden, from November 2014 to February 2020, were reviewed. Of 92 patients, node-positive disease was present in 15 (16%). Fifty-three patients underwent staged SLNB before mastectomy and IBR, and 10 (19%) presented with nodal metastasis. All patients with macrometastatic sentinel nodes were presented with palpable, multifocal, ER+ breast carcinoma of no special type with tumor size > 17.0 mm. Overall, four women received PMRT after verified metastasis by staged SLNB, and IBR was cancelled for three patients. These findings question the benefit of routine staged SLNB before mastectomy and IBR in breast cancer populations within established mammography screening programs with low risk of nodal metastasis.
即刻乳房重建(IBR)后进行乳房切除术后放疗(PMRT)与术后并发症相关。尽管淋巴结阳性乳腺癌的发病率在下降,但在计划进行IBR的乳房切除术前仍需单独进行前哨淋巴结活检(SLNB),以评估淋巴结状态及是否需要进行PMRT。本研究评估了分期SLNB对乳房重建规划的影响,并呈现了存在大转移灶淋巴结扩散的乳腺癌的常见临床病理特征,在此情况下分期SLNB有助于提示是否需要进行PMRT。回顾了2014年11月至2020年2月在瑞典斯坎纳大学医院计划进行乳房切除术和IBR的乳腺癌患者的病历。92例患者中,15例(16%)存在淋巴结阳性疾病。53例患者在乳房切除术和IBR前接受了分期SLNB,其中10例(19%)出现淋巴结转移。所有前哨淋巴结有大转移灶的患者均表现为可触及的、多灶性、ER阳性的非特殊类型乳腺癌,肿瘤大小>17.0 mm。总体而言,4名女性在分期SLNB证实转移后接受了PMRT,3例患者的IBR被取消。这些发现对在既定的乳房X线筛查项目中,淋巴结转移风险较低的乳腺癌人群在乳房切除术和IBR前常规进行分期SLNB的益处提出了质疑。